Scientists hunt for clues in blood and spinal fluid to speed up ALS drug development
NCT ID NCT03912987
Summary
This study aims to find and validate biological markers (biomarkers) in blood, urine, and spinal fluid from people with ALS and related disorders. The goal is to better understand the diseases and create tools to measure if future experimental treatments are working. It involves 610 participants, including people with ALS and healthy volunteers, who will be followed over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRONTOTEMPORAL DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kansas
Kansas City, Kansas, 66160, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.